Advertisement
Screener

CELCUITY INC. (CELC) Shareholder Equity

CELCUITY INC. (CELC) Shareholder Equity

  • 2026-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $49.00K; Additional Paid in CapitalUSD $567.77M; Retained Earnings (Accumulated Deficit)USD $-580.60M.
  • 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $48.00K; Additional Paid in CapitalUSD $555.22M; Retained Earnings (Accumulated Deficit)USD $-501.74M.
  • 2025-12-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $48.00K; Additional Paid in CapitalUSD $549.40M; Retained Earnings (Accumulated Deficit)USD $-448.90M.
  • 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $43.00K; Additional Paid in CapitalUSD $514.84M; Retained Earnings (Accumulated Deficit)USD $-397.92M.

CELCUITY INC. Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endPreferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
USD
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Warrant Issued
USD
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
USD
APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
USD
APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Other
USD
2026-06-30(m)$49.00K$567.77M$-580.60M$-12.78M(m)(m)(m)(m)(m)(m)(m)
2026-03-31(m)$48.00K$555.22M$-501.74M$53.52M(m)(m)(m)(m)(m)(m)(m)
2025-12-31(m)$48.00K$549.40M$-448.90M$100.56M(m)(m)(m)(m)(m)(m)(m)
2025-09-30(m)$43.00K$514.84M$-397.92M$116.96M(m)(m)(m)(m)(m)(m)(m)
2025-06-30(m)$39.00K$398.46M$-354.12M$44.38M(m)(m)(m)(m)(m)(m)(m)
2025-03-31(m)$38.00K$395.48M$-308.85M$86.67M(m)3 month · $2.44M(m)(m)(m)(m)(m)
2024-12-31$318.00$37.00K$387.44M$-271.86M$115.62M12 month · $263.73K(m)12 month · $1.23M(m)(m)(m)(m)
2024-09-30$318.00$37.12K$384.87M$-235.20M$149.71M(m)(m)(m)(m)(m)(m)(m)
2024-06-30$318.00$37.02K$382.06M$-205.41M$176.69M3 month · $264.00K(m)3 month · $1.23M(m)(m)(m)(m)
2024-03-31$505.00$30.77K$315.39M$-181.69M$133.74M(m)3 month · $1.33M(m)(m)(m)(m)(m)
2023-12-31$854.00$25.51K$299.82M$-160.08M$139.77M12 month · $614.21K(m)(m)(m)(m)(m)(m)
2023-09-30$1.06K$22.37K$234.10M$-141.23M$92.90M(m)(m)(m)(m)(m)(m)(m)
2023-06-30$1.09K$22.08K$232.93M$-122.82M$110.13M(m)(m)(m)(m)(m)(m)(m)
2023-03-31$1.10K$21.94K$231.44M$-108.24M$123.23M3 month · $7.49K3 month · $1.27M(m)(m)(m)(m)(m)
2022-12-31$1.12K$21.67K$230.05M$-96.30M$133.77M12 month · $389.76K(m)(m)(m)(m)(m)(m)
2022-09-30(m)$14.94K$128.23M$-84.72M$43.53M(m)(m)(m)(m)(m)(m)(m)
2022-06-30(m)$14.94K$127.00M$-73.82M$53.19M(m)(m)(m)(m)(m)(m)(m)
2022-03-31(m)$14.92K$125.39M$-63.86M$61.54M(m)3 month · $756.27K(m)3 month · $756.27K(m)(m)(m)
2021-12-31(m)$14.92K$124.62M$-55.93M$68.71M12 month · $3.87K(m)12 month · $289.84K(m)(m)(m)(m)
2021-09-30(m)$14.91K$123.63M$-49.17M$74.47M(m)(m)(m)(m)(m)(m)(m)
2021-06-30$0.00$12.65K$70.17M$-43.15M$27.03M(m)(m)3 month · $289.84K(m)(m)(m)(m)
2021-03-31$0.00$12.29K$64.28M$-29.11M$35.17M3 month · $3.87K(m)(m)3 month · $449.10K(m)(m)(m)
2020-12-31$0.00$10.30K$38.01M$-26.32M$11.70M(m)(m)(m)(m)(m)(m)(m)
2020-09-30$0.00$10.29K$37.52M$-23.77M$13.76M(m)(m)(m)(m)(m)(m)(m)
2020-06-30$0.00$10.29K$37.15M$-21.30M$15.86M(m)(m)(m)(m)(m)(m)(m)
2020-03-31$0.00$10.25K$36.60M$-19.09M$17.52M(m)(m)(m)(m)3 month · $464.65K(m)(m)
2019-12-31$0.00$10.25K$36.13M$-16.85M$19.30M(m)(m)(m)(m)12 month · $1.04M(m)(m)
2019-09-30$0.00$10.25K$35.74M$-15.04M$20.71M(m)(m)(m)(m)3 month · $218.91K3 month · $84.33K(m)
2019-06-30$0.00$10.22K$35.44M$-13.05M$22.39M(m)(m)(m)(m)3 month · $125.63K3 month · $66.61K(m)
2019-03-31$0.00$10.21K$35.19M$-11.33M$23.86M(m)(m)(m)(m)3 month · $184.65K3 month · $63.65K(m)
2018-12-31$0.00$10.19K$34.83M$-9.49M$25.35M(m)(m)(m)(m)12 month · $1.17M12 month · $144.46K(m)
2018-09-30$0.00$10.15K$34.57M$-7.66M$26.91M(m)(m)(m)(m)3 month · $220.81K3 month · $794.46K(m)
2018-06-30$0.00$10.12K$34.26M$-5.79M$28.48M(m)(m)(m)(m)3 month · $151.35K3 month · $124.94K(m)
2018-03-31$0.00$10.11K$33.91M$-3.98M$29.94M(m)(m)(m)(m)3 month · $157.01K3 month · $179.47K(m)
2017-12-31$0.00$10.09K$33.39M$-2.01M$31.39M(m)(m)(m)(m)12 month · $677.37K12 month · $197.01K12 month · $0.00
2017-09-30$0.00$10.08K$33.08M$-283.04K$32.81M(m)(m)(m)(m)9 month · $428.90K9 month · $132.19K9 month · $0.00
2016-12-31$0.00$0.00$593.37K$-8.33M$5.61M(m)(m)(m)(m)12 month · $141.41K12 month · $45.90K(m)
2015-12-31(m)(m)(m)(m)$5.02M(m)(m)(m)(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERACYTE, INC. (VCYT)United States$3.904B41.21
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B